SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 10 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,979,000 | -0.1% | 2,004,000 | +0.2% | 0.04% | -5.1% |
Q2 2021 | $1,980,000 | +2.3% | 2,000,000 | 0.0% | 0.04% | -7.1% |
Q1 2021 | $1,936,000 | -92.1% | 2,000,000 | -92.2% | 0.04% | -91.9% |
Q4 2020 | $24,403,000 | -38.0% | 25,556,000 | -40.1% | 0.52% | -40.1% |
Q3 2020 | $39,347,000 | -10.6% | 42,650,000 | -13.8% | 0.87% | -15.8% |
Q2 2020 | $43,994,000 | +3.1% | 49,490,000 | -6.1% | 1.03% | +11.1% |
Q1 2020 | $42,668,000 | -5.9% | 52,691,000 | +5.5% | 0.93% | +5.6% |
Q4 2019 | $45,350,000 | -19.6% | 49,922,000 | -17.7% | 0.88% | -16.8% |
Q3 2019 | $56,413,000 | -6.4% | 60,655,000 | -1.7% | 1.06% | -9.3% |
Q2 2019 | $60,252,000 | +21.9% | 61,727,000 | +20.5% | 1.17% | +7.0% |
Q1 2019 | $49,416,000 | – | 51,234,000 | – | 1.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 46,902,000 | $45,737,000 | 4.40% |
INCOME RESEARCH & MANAGEMENT | 7,500,000 | $7,280,000 | 3.12% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $94,477,000 | 2.13% |
PIPER SANDLER & CO. | 2,200,000 | $2,112,000 | 1.92% |
DeepCurrents Investment Group LLC | 41,092,000 | $39,934,000 | 1.59% |
Radcliffe Capital Management, L.P. | 69,010,000 | $66,983,000 | 1.54% |
Sonora Investment Management Group, LLC | 9,635,000 | $9,389,000 | 0.89% |
Penn Mutual Asset Management | 675,000 | $656,000 | 0.88% |
OAKTREE CAPITAL MANAGEMENT LP | 24,447,000 | $23,851,000 | 0.28% |
WOLVERINE ASSET MANAGEMENT LLC | 8,681,000 | $8,429,000 | 0.08% |